Haines Timothy

CIK 00015260683 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001526068

Recent Transactions

27 trades

Conversion
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2019-11-12−126→ 2,400 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock, $0.001 par value
2019-11-12$0.99/sh+126,645→ 2,144,517 total
Award
PROJECT SAGE OLDCO, INC.
Common Stock (RSUs)
2019-06-14+19,320→ 56,982 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock
2018-11-06$21.13/sh−8,514→ 2,471,980 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock
2018-11-06$21.60/sh−81,137→ 2,390,843 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2018-06-08+12,700→ 12,700 total
Award
PROJECT SAGE OLDCO, INC.
Common Stock (RSUs)
2018-06-05$20.44/sh+6,116→ 37,662 total
Purchase
PROJECT SAGE OLDCO, INC.
Common Stock
2018-05-07$13.50/sh+281,482→ 2,480,494 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+2,526→ 2,526 total
Award
PROJECT SAGE OLDCO, INC.
Common Stock
2017-06-22$9.72/sh+12,861→ 31,546 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2017-06-20+6,666→ 6,666 total
Award
PROJECT SAGE OLDCO, INC.
Common Stock
2016-06-23$6.69/sh+18,685→ 18,685 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2016-06-09+6,666→ 6,666 total
Award
PROJECT SAGE OLDCO, INC.
Stock Option (right to buy)
2015-06-26+7,037→ 7,037 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2015-06-02+6,666→ 6,666 total
Purchase
PROJECT SAGE OLDCO, INC.
Common Stock
2014-10-29$15.00/sh+495,000→ 2,199,012 total
Conversion
Protara Therapeutics, Inc.$TARA
Series D Convertible Preferred Stock
2014-10-27−16,044,081→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27+1,067,872→ 2,017,872 total
Other
Protara Therapeutics, Inc.$TARA
Option (Right to Purchase)
2014-10-27−12,835,264→ 0 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh+950,000→ 950,000 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2013-10-11−50,000→ 0 total
Disposition to Issuer
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2013-10-11−32,500→ 0 total
Award
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2013-06-13+12,500→ 12,500 total
Award
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2013-06-13+20,000→ 20,000 total
Award
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2012-06-22+12,500→ 12,500 total
Award
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2012-06-22+20,000→ 20,000 total
Award
Astex Pharmaceuticals, Inc
Director Stock Option (Right to buy)
2011-07-20+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O ABINGWORTH LLP 38 JERMYN STREET

LONDON, X0, SW1Y 6DN

View on SEC.gov